WE’RE COMMITTED TO REAL IMPACT
CANCER FUND invests to move cancer innovations BEYOND RESEARCH from the lab to patients – to save lives.
Because research alone isn’t enough.
How we’re different
We turn hope into reality. CANCER FUND invests in companies turning promising innovations into breakthrough treatments and care that impact lives.
More than giving
You give to charities. You invest in CANCER FUND and can share in profits generated from our portfolio. And you can start with as little as $500.
Know where your money is going. We’ll share the innovations your investment is funding and how it aims to benefit patient care, and you.
CANCER FUND works to make a difference in the fight against cancer. We invest in innovations to improve patient outcomes, expand access to care, and reduce the cost of care for patients, survivors, and individuals at risk of developing:
- Breast Cancers
- Childhood Cancers
- Lung Cancers
- Prostate Cancers
- Glioblastoma and other Brain Cancers
- Colon Cancers
- Other Cancers
Members of our community
CANCER SURVIVOR AND CANCER FUND INVESTOR
CANCER DONOR TURNED CANCER FUND INVESTOR
How CANCER FUND works
Who can invest in CANCER FUND?
For accredited investors, our minimum investment is $500. We have kept the minimum investment low to encourage broad participation.
For non-accredited investors, we want to open CANCER FUND I up to everyone. You can help us get there faster by expressing your interest. Just click here to register, and we’ll add you to our list of interested but non-accredited investors
How much can I invest in CANCER FUND I?
The MINIMUM investment in CANCER FUND I is $500 and you can invest any amount in increments of $100, subject to approval of the Fund’s Managing Director.
For larger investors, we offfer additional opporunities to be involved in our mission and investment decisions. You can learn more here.
How much can I expect in return?
CANCER FUND I invests in ultra high-risk, early-stage companies. Returns on some early stage companies can be significant, but there is no assurance CANCER FUND I will realize those returns. In fact, most of these early-stage companies fail and result in a total loss of their investors capital. Investors who cannot afford to lose their entire investment should not invest in CANCER FUND I. The primary investment objective of CANCER FUND I is impact, not financial returns.
Further, CANCER FUND and CANCER FUND I do not make investment recommendations or provide financial advice or advisement. We encourage you to speak with your financial advisor to determine what level of investment makes sense for you, if any at all. If you’d like, we’re happy to discuss the CANCER FUND opportunity with your financial advisor. If you don’t have a financial advisor, we can share a directory with you or you can access it here.
How do I start investing in CANCER FUND?
You start by creating an account through our investment platform, Funds411.com. CANCER FUND uses Funds411 as ann independent way to manage investor enrollment, communication and other fund management tasks. You can create your account here.
What’s the difference between CANCER FUND and CANCER FUND I?
CANCER FUND is a venture capital company that oversees our overall mission and manages our investment activities and portfolio. As a company, CANCER FUND is subject to all applicable state and federal regulations.
Money committed by investors are invested into specific funds (not our compnany) with specific investment objectives. CANCER FUND I is our first investment fund and operates in compliance with guildelines set by the Securities and Exchange Commission.
What does CANCER FUND invest in?
CANCER FUND invests in early stage companies in three broad areas of focus:
1. Therapies & Management
2. Diagnostics & Monitoring
3. Preventions & Enabling TechnologiesW
We invest in innovations to benefit four different groups of stakeholders: 1. Patients and Families
2. Medical Professionals and Caregivers
3. At Risk Populations
4. Payers and Policy Makers
We invest in the gap that is too late for research grants but too early for most venture capitalists. We focus on Pre-Seed, Seed, Seed+, and Series A funding rounds.
How are companies identified and chosen for CANCER FUND I?
CANCER FUND I focuses on early-stage companies that can be difficult to identify. Sometimes companies find us, sometimes we find them through our research and scouting efforts. We currently have identified over 130 innovative cancer companies seeking more than $1.2B in funding and that list is constantly expanding.
Once a company has been identified, it is reviewed by CANCER FUND’s Screening Committee for fit with our impact and investment criteria. Select companies are introduced to the public and our community through The Lowdown on Cancer, our public community on Facebook. This is an opportunity for our community to actively participate in selecting which innovations we consider for investment.
If the Screening Committee recommends a company for further consideration, a due diligence evaluation is completed by the CANCER FUND Evaluation Committee which may recommend investment be made. The CANCER FUND Investment Committee makes all final investment decisions and manages the investment portfolio.
What companies has CANCER FUND I invested in?
CANCER FUND completed its first investment in February 2021 by investing in Relagene, an epigenetic medicine company developing orally-administered medications to control gene expression and prevent cancer genes from developing therapy resistance. The press announcement of the investment can be found here.
We get it. Donating to cancer causes is easy while investing seems complicated and risky. You might even lose all of your money . . . just like donating. With CANCER FUND, you invest to help cancer innovations reach patients and maybe earn a return on your money . . . not at all like donating.